Table 5.

Distribution of Variant Genotypes of SH-FcγRIIIb in Individuals, as Determined by SfaN1 Digestion of PCR Fragments Amplified With NA2-Specific Primers

AA CA
Positive Amplification With Primers Corresponding to Pattern of SfaN1 Digestion Positive Amplification With Primers Corresponding to Pattern of SfaN1 Digestion
NA1 + NA2  CC  44 (66%)  NA1 + NA2  CC 80 (94%)  
 AC  14 (21%)   AC  4 (5%) 
 AA  9 (13%)   AA  1 (1%)  
NA2 only  CC 36 (64%)  NA2 only  CC  69 (96%)  
 AC 15 (26%)   AC  3 (4%)  
 AA 5 (9%)   AA  0 (0%) 
χ2 = 1.0 P = .60  χ2 = .88 P = .64  
AA CA
Positive Amplification With Primers Corresponding to Pattern of SfaN1 Digestion Positive Amplification With Primers Corresponding to Pattern of SfaN1 Digestion
NA1 + NA2  CC  44 (66%)  NA1 + NA2  CC 80 (94%)  
 AC  14 (21%)   AC  4 (5%) 
 AA  9 (13%)   AA  1 (1%)  
NA2 only  CC 36 (64%)  NA2 only  CC  69 (96%)  
 AC 15 (26%)   AC  3 (4%)  
 AA 5 (9%)   AA  0 (0%) 
χ2 = 1.0 P = .60  χ2 = .88 P = .64  

SfaN1 digestion of amplicon generated with NA2-specific oligonucleotide primers was analyzed by agarose gel; SH-FcγRIIIb can only be detected in individuals in whom a product can be amplified with NA2-specific primers. Digestion by SfaN1 indicates the presence of the SH-FcγRIIIb sequence. Specifically, a nucleotide change at position 266 from C to A results in a change of alanine to aspartic acid at residue 78. Data were analyzed using a 3 × 2 χ2test for heterogeneity with 2 degrees of freedom. Sequence difference at nucleotide position 266: C, reported NA2 sequence; A, SH-FcγRIIIb.

or Create an Account

Close Modal
Close Modal